An independent tribunal has suspended Argentinian tennis player Romeo Arcuschin for a period of 20 months for breaching tennis’ anti-doping rules.
19-year-old Arcuschin, who reached a career-high world singles ranking of 1802 in November 2025, has been provisionally suspended since 16 February 2026, after testing positive for two prohibited substances - stanozolol and clomifene - at a World Tennis Tour event in Lima, Peru, in December 2025.
While Arcuschin accepted the presence of both substances in their sample, the player and the ITIA did not reach agreement on the level of fault, so the case was referred to an independent tribunal.
Following a hearing, which was held on 11 August 2026, the tribunal accepted that Arcuschin had sought treatment from an experienced sports doctor following a period of injury, surgery, and rehabilitation.
The doctor prescribed a 30-day course of compounded medications containing both stanozolol and clomifene, which Arcuschin completed, unintentionally ingesting the prohibited substances in the process.
The tribunal found that the doctor had chosen not to inform Arcuschin of the substances prescribed as part of the treatment for muscle atrophy, and the medication itself was provided in unlabelled containers.
In determining sanction, the tribunal accepted that Arcuschin’s breaches were unintentional and considered that the player’s level of fault was reduced in part due to the actions of the doctor, and in part because of their age and limited understanding of anti-doping rules.
Time served under provisional suspension is credited against the sanction. As such, Arcuschin’s sanction ends on 17 October 2027.
Separately, 26-year-old American tennis player Salma Ewing has been provisionally suspended under tennis’ anti-doping rules.
Ewing, who reached a career-high world singles ranking of 652 in July 2018, tested positive for the prohibited substance amfetamine during an in-competition test at a World Tennis Tour event in San Diego, USA, on 1 July 2026.
Amfetamine is classed as a stimulant on the World Anti-Doping Agency (WADA) Prohibited List. Because of the nature of the substance, a provisional suspension is mandatory.
The provisional suspension took effect on 20 August 2026. Ewing has the right to appeal the provisional suspension but has not done so to date.
As with all Tennis Anti-Doping Programme cases, ITIA support is available to Ewing.
While suspended, Arcuschin and Ewing are not allowed to play in, coach at, or attend any events organised or sanctioned by World Tennis, WTA, ATP, the Grand Slams, or any national association.
To read the Arcuschin decision in full, click here.
Ends
Published 14 September 2026 14:00
